- BOLT -0.34%
Is Bolt Biotherapeutics (NASDAQ:BOLT) In A Good Position To Deliver On Growth Plans?
Yahoo Finance · 1 week ago
Open | 1.1000 |
High | 1.1000 |
Low | 1.0800 |
Mkt Cap | 41.8M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 1.1000 |
52 Wk. Low | 0.8400 |
52 Wk. High | 2.0300 |
Related stocks
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 2.09M | 48.10% ▲ |
Net Income | -17.9M | - |
Diluted EPS | -0.47 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | -$0.51 | - |
Q4 2023 | -$0.48 | -$0.47 |
Q3 2023 | -$0.50 | -$0.43 |
S&P 500^GSPC | 5,158.23+30.44 (+0.59%) |
Dow 30^DJI | 38,736.90+61.22 (+0.16%) |
Nasdaq^IXIC | 16,268.90+112.57 (+0.70%) |
24.92+6.84% | |
20.76+18.48% | |
917.53+3.34% |